TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD34+ cell repopulation in NOD/SCID mice | Charles Explorer

TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD34+ cell repopulation in NOD/SCID mice

Publication

Abstract

Inhibits myelodysplasia, myeloid leukemia

People